Small Business Resources, Business Advice and Forms from AllBusiness.com

The Medicines Company to Present at the Annual 2006 Stanford Growth Conference.

PARSIPPANY, N.J. -- The Medicines Company (NASDAQ:MDCO) is scheduled to present at the Stanford Growth Conference on Tuesday, November 14th, at 2:30 pm Eastern Time in New York City. A company overview and outlook will be provided in the presentation.

The session will be webcast with a

link available at The Medicines Company's website: http://www.themedicinescompany.com.

About The Medicines Company

The Medicines Company meets the demands of the world's most advanced medical practitioners by developing products that improve acute hospital care. The Company markets Angiomax[R] (bivalirudin), an anti-clotting therapy approved in the U.S. and other countries for use in patients undergoing coronary angioplasty, a procedure to clear restricted blood flow in arteries around the heart. The Medicines Company creates value using its range of clinical and commercial skills to develop products acquired from leading life science innovators.

In addition, make sure to read these articles: